(Q36620382)

15 August 2017

Oral topotecan: bioavailablity and effect of food co-administration (English)

1 reference

15 August 2017

W W ten Bokkel Huinink

3

object named as

ten Bokkel Huinink WW

1 reference

15 August 2017

Herben VM

1

1 reference

15 August 2017

Rosing H

2

1 reference

15 August 2017

van Zomeren DM

4

1 reference

15 August 2017

Batchelor D

5

1 reference

15 August 2017

Doyle E

6

1 reference

15 August 2017

Beusenberg FD

7

1 reference

15 August 2017

Beijnen JH

8

1 reference

15 August 2017

Schellens JH

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

80

1 reference

15 August 2017

9

1 reference

15 August 2017

1380-1386

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690532

15 August 2017

0 references

cites work

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Review of methods and criteria for the evaluation of bioequivalence studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363072

Comprehensive criteria for assessing therapy-induced toxicity

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10424739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Equilibrium kinetics of the new experimental anti-tumour compound SK&F 104864-A in aqueous solution

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10424739

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6690532

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

10424739

1 reference